Loss of placental growth factor protects mice against vascular permeability in pathological conditions.
暂无分享,去创建一个
A. Luttun | P. Carmeliet | L. Moons | D. Collen | J. Herbert | K. Brusselmans | M. Tjwa | O. Matsuo | S. Ueshima | H. Fukao
[1] Lawrence A. Yannuzzi,et al. PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION , 2002, Retina.
[2] L. Iversen,et al. Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability , 2001, Nature Medicine.
[3] Till Acker,et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.
[4] P. Scheurich,et al. A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. , 2001, Blood.
[5] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] Michael Chopp,et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke , 2001, Nature Medicine.
[7] G. Tosato,et al. Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Primary Effusion Lymphomas , 2001, Leukemia & lymphoma.
[8] J. Isner,et al. Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor , 2000, Annals of Internal Medicine.
[9] R. Crystal,et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. , 2000, American journal of respiratory cell and molecular biology.
[10] J. Wilson. The bronchial microcirculation in asthma. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] K Miyamoto,et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). , 2000, The American journal of pathology.
[12] N. Glazer,et al. Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.
[13] D. Fairlie,et al. Cell phenotype as a target of drug therapy in chronic inflammatory diseases. , 2000, Medical hypotheses.
[14] N. van Bruggen,et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.
[15] P. Schwartzberg,et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.
[16] M. Marrero,et al. Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src* , 1999, The Journal of Biological Chemistry.
[17] R K Jain,et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. , 1999, Cancer research.
[18] R. Jain,et al. Effect of local anti-VEGF antibody treatment on tumor microvessel permeability. , 1999, Microvascular research.
[19] M. Shibuya,et al. A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain* , 1998, The Journal of Biological Chemistry.
[20] N. Ferrara,et al. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. , 1998, The American journal of pathology.
[21] Gustafsson,et al. Allergen challenge‐induced extravasation of plasma in mouse airways , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[22] R K Jain,et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.
[23] K. Alitalo,et al. A Recombinant Mutant Vascular Endothelial Growth Factor-C that Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities* , 1998, The Journal of Biological Chemistry.
[24] I. Shiels,et al. Vascular leakage stimulates phenotype alteration in ocular cells, contributing to the pathology of proliferative vitreoretinopathy. , 1998, Medical hypotheses.
[25] J. Isner,et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. , 1998, Circulation.
[26] E. Vitetta,et al. Vascular leak syndrome: a side effect of immunotherapy. , 1997, Immunopharmacology.
[27] Hidehiro Ishii,et al. Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.
[28] L. Hinshaw,et al. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. , 1996, Critical care medicine.
[29] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[30] J. Severinghaus. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. , 1995, Journal of applied physiology.
[31] J. Winer,et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.
[32] N. Mcclure,et al. Image analysis quantification of the Miles assay. , 1994, Journal of pharmacological and toxicological methods.
[33] M. Gentle,et al. Neurogenic inflammation in the chicken (Gallus gallus var domesticus). , 1993, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.
[34] H. Dvorak,et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.
[35] G. Viglietto,et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Province,et al. Modulation of Hemodynamic and Vascular Filtration Changes in Diabetic Rats by Dietary myo-inositol , 1990, Diabetes.
[37] J. Casals-stenzel. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. , 1987, Immunopharmacology.
[38] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[39] F. Plum,et al. Edema and Vascular Permeability in Cerebral Ischemia: Comparison Between Ischemic Neuronal Damage and Infarction , 1982, Journal of neuropathology and experimental neurology.
[40] O. Matsuo,et al. Analysis of fluid in capsules implanted into dog brain. , 1974, The Japanese journal of physiology.
[41] A. Luttun,et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.
[42] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[43] A. Wilks,et al. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. , 1997, Growth factors.
[44] D. Maglione. Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor , 1991 .